Advertisement

Topics

Latest "ProCyte Corporation" News Stories

16:22 EDT 25th April 2018 | BioPortfolio

Here are the most relevant search results for "ProCyte Corporation" found in our extensive news archives from over 250 global news sources.

More Information about ProCyte Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ProCyte Corporation for you to read. Along with our medical data and news we also list ProCyte Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of ProCyte Corporation Companies for you to search.

Showing "ProCyte Corporation" News Articles 1–25 of 278

Wednesday 25th April 2018

LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance

Effective January 1, 2018, the Company adopted the new revenue recognition accounting standard (ASC 606) and restated financial results for 2016 and 2017. Unless otherwise indicated, all financial results in 2017 and comparisons to financial results in 2017 have been restated in these bullets and this press release as if the Company had ...


Monday 23rd April 2018

PROTHENA CORPORATION INVESTOR ALERT: Girard Gibbs Investigates Potential Securities Law Violations

Girard Gibbs LLP is investigating claims on behalf of investors of Prothena Corporation (NASDAQ: PRTA) involving possible securities law violations. Specifically, our investigation focuses on whether Prothena issued materially misleading business information to the investing public or engaged in other unlawful business practices. To speak privatel...

Prothena Discontinues Development of NEOD001 for AL Amyloidosis

Phase 2b PRONTO study did not meet its primary or secondary endpoints Phase 3 VITAL Amyloidosis Study being discontinued based on futility analysis Investor conference call and webcast today at 8:30 AM ET DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel ther...


Sunday 22nd April 2018

20152023 World Carbon Disulphide Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 21022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Friday 20th April 2018

Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook

ORION CORPORATION         STOCK EXCHANGE RELEASE   21 APRIL 2018     at  01.30  a.m. EEST         Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook   Orion Corporation ("Orion") announced on 23 January 2018 that it was evaluating strategic alternatives of the Group's Orion ...

Thursday 19th April 2018

Chemed Reports First-Quarter 2018 Results

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest provider of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2018, versus the comparable prio...

Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 2018

Conference call scheduled for Thursday, April 26, 2018, at 8:30 a.m. ET UTRECHT, The Netherlands, April 19, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the Company will report full year 2017 financial results on Thursday, April 26, 2018. Merus' ma...

Wednesday 18th April 2018

Cambrex Corporation to Provide Additional Information Regarding its Environmental, Social and Governance Practices

EAST RUTHERFORD, N.J., April 19, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced a commitment to provide its stockholders with additional information regarding its environmental, social and governance (ESG) practices.  Cambrex’s commitment to the environment, ...

International Business Machines Corp - Doc re 8-K

International Business Machines Corp - Doc re 8-K PR Newswire London, April 18 Company INTERNATIONAL BUSINESS MACHINES CORPORATION TIDM IBM Headline Notification of filing of document The Corporat...

Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole

Basilea Pharmaceutica AG / Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, Switzerland, April 18, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its license partner...

Tuesday 17th April 2018

Novartis tender offer for AveXis commences

Novartis International AG / Novartis tender offer for AveXis commences . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, April 17, 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that its indirect wholly-owned subsidiary, Novartis AM Merger Corporation, a Delaware corporation...

Thursday 12th April 2018

20152023 World Modified Rosin Resins Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 25022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Wednesday 11th April 2018

Evotec Forms Collaboration with Petra Pharma on Indigo Platform

* PETRA PHARMA CORPORATION TO HARNESS EVOTEC'S INDIGO PLATFORM TO ACCELERATE ITS LEAD PROGRAMME (PETRA-01 FOR ONCOLOGY INDICATIONS) THROUGH IND FILING * EVOTEC ELIGIBLE TO RECEIVE SUCCESS-BASED MILESTONES AND RESEARCH FUNDING * EVOTEC'S INDIGO, A KEY VALUE-DRIVING COMPONENT OF ITS EVT EXECUTE BUSINESS SEGMENT, ACCELERATES EARLY DRU...

Tuesday 10th April 2018

HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)

Study demonstrates promising new capabilities for MyoVista® ECG device in detecting Abnormal Cardiac Function SOUTHLAKE, Texas, April 10, 2018 - (BioPortfolio) HeartSciences, a medical device company leading innovation in electrocardiography through the application of continuous wavelet transform (CWT) signal processing and artificial intelligence announced today the results of a c...

Publishing of Orion Corporation's Interim Report for January-March 2018 on 24 April 2018

ORION CORPORATION     PRESS RELEASE   10 APRIL 2018 at 12.00 EEST Publishing of Orion Corporation's Interim Report for January-March 2018 on 24 April 2018 Orion will publish its Interim Report for January-March 2018 on Tuesday, 24 April 2018 approximately at 12.00 noon Finnish time (EEST). The release and related presentation material in Finnish and in English wil...

Monday 9th April 2018

International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results

CARLSBAD, Calif., April 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the period en...

20152023 World Polyvinyl Alcohol Films Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 25022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Sunday 8th April 2018

Cerecor Appoints Simon Pedder to its Board of Directors

BALTIMORE, MD--(Marketwired - April 09, 2018) - Cerecor, Inc. (NASDAQ: CERC), today announced that Simon C. Pedder, Ph.D. has been appointed to its Board of Directors. "We are delighted to welcome Dr. Pedder to our Board." said Dr. Uli Hacksell, Chairman of the Board of Cerecor, "With his experience in all stages of drug development and collaborating with the FDA on several products leading to a...

Saturday 7th April 2018

20152023 World Instant Adhesive Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Wednesday 4th April 2018

20152023 World Antiblock Additive Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 15022018] Prices from USD $2800

SummaryxxxThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Ame...

Tuesday 3rd April 2018

Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study

OTTAWA, ONTARIO -- (Marketwired) -- 04/04/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the initiation of screening and enrolment activities in the Phase 3 study of its PPP001 smokable cannabis pellet for advanced cancer patients with uncontrolled pain. Tetra authorized the initiation of the patient enrolment activities at its main cli...

Stryker announces organizational changes: Lonny J. Carpenter to retire

Kalamazoo, Michigan - April 3, 2018 - Stryker Corporation (NYSE:SYK) announced today that after 30 years of distinguished service, Lonny Carpenter, Group President, Global Quality and Business Operations has notified the Company of his intent to retire on March 31, 2019. Mr. Carpenter will transfer his responsibility for Global Quality and Operations to Viju Menon, as outli...

Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer

ORION CORPORATION                               PRESS RELEASE                3 APRIL 2018 at 10.30 EEST           Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer    Orion announced today that the estimated primary completion ...

Monday 2nd April 2018

Tetra Bio-Pharma Names Guy Chamberland as Interim CEO

OTTAWA, ONTARIO -- (Marketwired) -- 04/03/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the appointment of Guy Chamberland, M.Sc., Ph.D., an accomplished drug developer, as interim Chief Executive Officer (CEO). This appointment is effective immediately. Dr. Chamberland has been Chief Scientific Officer & Regulatory Affairs of Tetra...

XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer

Agreement Centers on XBiotech's Proprietary Manufacturing Technology to Advance Anti-NY-ESO-1 Antibody 12D7 AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- XBiotech USA, Inc. (NASDAQ:XBIT) announced today that it has obtained an exclusive, worldwide license from CT Atlantic AG (CTA), a Swiss biotechnology company.  Under the terms of the license agreement, XBiotech will use its pr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks